Revolutionizing Surgery: India’s First CDSCO Certified Robotic System Takes the Lead – Introducing SSi Mantra
Description:
SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement in surgical robotics. SS Innovations reinforces India’s position as a hub for technological innovation in healthcare using the SSi Mantra – Made in India, for the World. The SSi Mantra integrates innovative advancements in robotic surgery, offering surgeons enhanced precision and control for improved patient outcomes. FORT LAUDERDALE, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has achieved a milestone in Indian medical science by becoming the first and only company in India to receive Central Drugs Standard Control Organization (CDSCO) regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, signifying a significant achievement in surgical robotics.
Impact on Individuals:
Individuals, especially patients requiring surgery, will benefit greatly from the introduction of India’s first CDSCO certified robotic system, SSi Mantra. With enhanced precision and control offered by the robotic system, patients can expect improved outcomes and faster recovery times. The Telesurgery and Teleproctoring capabilities also enable remote surgery and supervision, ensuring patients in remote areas have access to top-quality surgical care without the need to travel to urban centers.
Impact on the World:
The introduction of SSi Mantra by SS Innovations marks a significant advancement in surgical robotics not only for India but for the world. By making world-class robotic surgery affordable and accessible to a global population, SS Innovations is paving the way for the widespread adoption of robotic surgery in healthcare systems worldwide. The integration of innovative advancements in robotic surgery will revolutionize the way surgeries are performed, leading to better patient outcomes and overall improvements in healthcare quality on a global scale.
Conclusion:
In conclusion, the launch of India’s first CDSCO certified robotic system, SSi Mantra, by SS Innovations is a groundbreaking achievement in the field of surgical robotics. With its Telesurgery and Teleproctoring capabilities, the SSi Mantra offers enhanced precision and control to surgeons, ultimately leading to improved patient outcomes. This technological innovation not only reinforces India’s position as a hub for healthcare innovation but also sets a new standard for robotic surgery on a global scale. The world can now look forward to a future where advanced robotic systems like SSi Mantra revolutionize surgery and make high-quality care accessible to all.
